ArticleStem cell research & therapy2025

Intravenous mesenchymal stem cell transplantation mitigates pulmonary vascular remodeling but poses dose related risks in a pulmonary veno-occlusive disease model.

Junko Katagiri et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.